Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

797 ARTÍCULOS , VIENDO DEL 481 AL 495

Efficacy and Safety of Natural Apigenin Treatment for Alzheimer's Disease: Focus on In vivo Research Advancements

Zhang N, Nao J, Dong X.

Curr Neuropharmacol. 2025;23(6):728-754. doi: 10.2174/1570159X23666241211095018.

Alzheimer's Disease May Benefit from Olive Oil Polyphenols: A Systematic Review on Preclinical Evidence Supporting the Effect of Oleocanthal on Amyloid-β Load

Zupo R, Castellana F, Panza F, Solfrizzi V, Lozupone M, Tardugno R, Cicero N, Corbo F, Crupi P, Sardone R, Clodoveo ML.

Curr Neuropharmacol. 2025;23(10):1249-1259. doi: 10.2174/011570159X327650241021115228.

Can ketamine therapy overcome treatment-resistant depression in Alzheimer's disease and older adults? Preclinical and clinical evidence

Mario A, Ivana L, Claudia MM, Antonello B, Francesco P, Tommaso C, Madia L.

Biomed Pharmacother. 2025 Jul;188:118199. doi: 10.1016/j.biopha.2025.118199. Epub 2025 May 23.

Practical Brain MRI Guidelines for Anti-Aβ Antibody Treatment in Early Symptomatic Alzheimer's Disease

Kakeda S, Miki Y, Kudo K, Mori H, Tokumaru AM, Abe O, Aoki S; Working Group for Brain MRI Guidelines for Anti-Aβ Antibody Treatment from The Japan Radiological Society, The Japanese Society for Neuroradiology, and The Japanese Society for Magnetic Resonance in Medicine.

Magn Reson Med Sci. 2025 Nov 20;24(4):2025-1000. doi: 10.2463/mrms.gl.2025-1000. Epub 2025 Apr 5.

Randomized controlled trial of Bushen Yinao pill combined with conventional therapy on intestinal flora and cognitive function in older patients with Alzheimer's disease

Wang W, Zhang J, Li C.

Int J Psychiatry Med. 2025 May;60(3):280-295. doi: 10.1177/00912174241290962. Epub 2024 Dec 12.

Brain morphological characteristics predicting clinical response to selective serotonin reuptake inhibitors or cholinesterase inhibitors: A study of electronic medical records in patients with cognitive disorders

Onda K, Chotiyanonta JS, Cowley HP, Uchida Y, Nowrangi MA, Adams R, Lyketsos CG, Zandi PP, Oishi K.

Int Psychogeriatr. 2025 Dec;37(6):100105. doi: 10.1016/j.inpsyc.2025.100105. Epub 2025 Jun 25.

Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer Disease: Intersocietal Recommendations for Their Appropriate Use in Switzerland

Felbecker A, Felbecker A, Rouaud O, Lathuiliere A, Allali G, Sollberger M, Meyer-Heim T, Monsch AU, Lövblad KO, Becker S, Barro-Belaygues N, Popp J, Bürge M, Lindheimer K, Gietl A, Jung HH, Georgescu D, Meyer R, Frisoni GB.

Neurodegener Dis. 2025;25(3):114-125. doi: 10.1159/000545799. Epub 2025 Apr 14.

Financial Incentives to Increase Diversity of Older Participants in a Memory Concerns Registry: A Randomized Clinical Trial

Jacobson M, Molina-Henry D, Chang TY, Jimenez-Maggiora GA, Pramanik R, Shah SB, Aisen PS.

JAMA Health Forum. 2025 Aug 1;6(8):e252273. doi: 10.1001/jamahealthforum.2025.2273.

Effect of donepezil on bone metabolism among older adults with Alzheimer's disease

North R, Liu AJ, Pieper C, Danus S, Thacker CR, Ashner M, Colón-Emeric C, Lee RH.

Contemp Clin Trials. 2025 Jan;148:107748. doi: 10.1016/j.cct.2024.107748. Epub 2024 Nov 19.

Practical brain MRI guidelines for anti-Aβ antibody treatment in early symptomatic Alzheimer's disease

Kakeda S, Miki Y, Kudo K, Mori H, Tokumaru AM, Abe O, Aoki S; Working Group for Brain MRI Guidelines for Anti-Aβ Antibody Treatment from The Japan Radiological Society, The Japanese Society for Neuroradiology, and The Japanese Society for Magnetic Resonance in Medicine.

Jpn J Radiol. 2025 Aug;43(8):1231-1238. doi: 10.1007/s11604-025-01773-x. Epub 2025 Apr 23.

Safety and efficacy of sodium benzoate for patients with mild Alzheimer's disease: a systematic review and meta-analysis

Mansour MEM, Ali AHG, Ibrahim MHM, Mousa AIA, Negida AS.

Nutr Neurosci. 2025 Jun;28(6):763-772. doi: 10.1080/1028415X.2024.2415867. Epub 2024 Oct 25.

Efficacy, Immunogenicity, Safety, and Tolerability of AADvac1 in Alzheimer Disease: A Systematic Review and Meta-Analysis of Placebo-Controlled Trials

Pereira da Silva AM, Falcão Carneiro Filho L, Virgilio Ribeiro F, Rodrigues Menezes I, Leite M, Honorato de Farias E, Nascimento MDV, Silva Corin A, Gonçalves Quiroga D, Franco ES, de Sousa Maia MB.

Alzheimer Dis Assoc Disord. 2025 Oct-Dec 01;39(4):334-341. doi: 10.1097/WAD.0000000000000686. Epub 2025 Aug 18.

Evaluating the Therapeutic Effects of Oxytocin on Animal Model of Alzheimer's Disease: A Systematic Review

Shafigh E, Sadeghi G, Jamaat NA, Hassanpour F, Solhirad M, Karimi-Zandi L.

Curr Alzheimer Res. 2025;22(4):255-265. doi: 10.2174/0115672050386593250521064527.

Recruitment and retention in a preclinical AD trial: comparisons between academic and non-academic sites

Ritchie M, Hussen K, Langford O, Navarro C, Kotadiya Z, Donohue MC, Aisen P, Sperling RA, Grill JD, Raman R.

Alzheimers Res Ther. 2025 Oct 14;17(1):222. doi: 10.1186/s13195-025-01867-8.

Systematic Review on Neurotoxic Implications of Lead-Induced Gene Expression Alterations in the Etiology of Alzheimer's Disease

Parithathvi A, Harshitha P, Mumbrekar KD, Dsouza HS.

Cell Mol Neurobiol. 2025 Nov 7;45(1):98. doi: 10.1007/s10571-025-01613-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias